Genes of the immune system cosegregate with the age at onset of diabetes in the BB/OK rat

Biochemical and Biophysical Research Communications
I Klöting, P Kovács

Abstract

The knowledge of genetic factors determining the age at onset of diabetes may help to delay the development of diabetes and its complications. This prompted us to use our well-characterized BB/OK rat whose age at onset of diabetes can change from 50 to more than 400 days for crossing studies to search for loci cosegregating with the age at onset. Fifty-nine diabetic first backcross hybrids resulting from crosses between diabetic BB/OK and diabetes-resistant DA and SHR rats were genotyped with PCR-analyzed microsatellite markers located on 21 chromosomes. Loci on chromosomes 6 (Ighe -D6Mgh2) and 8 (D8Mit2- Apoc3) were linked with the age at onset. Hybrids which were homozygous for the BB alleles developed significantly earlier diabetes than hybrids which were heterozygous The difference between the age at onset of heterozygous and homozygous hybrids reached a maximum at the loci Ighe on chromosome 6 (+ 32 days, p = 0.0018) and D8Mit2 on chromosome 8 (+ 28 days, p = 0.007). Candidate genes around the loci linked with the age at onset of diabetes are involved in the humoral and cellular immune response. For the first time, this study provides evidence that genetic factors can affect the age at onset of diabetes in the rat.

References

Nov 1, 1990·The Journal of Heredity·X Montagutelli
Nov 3, 1988·The New England Journal of Medicine·B AlarconC Terhorst
Jan 1, 1985·Cytogenetics and Cell Genetics·K H Grzeschik, H H Kazazian
Jan 1, 1995·Advances in Experimental Medicine and Biology·V Pascual, J D Capra

❮ Previous
Next ❯

Citations

Jul 2, 2004·ILAR Journal·John P MordesDale L Greiner
Oct 29, 2002·Diabetes·John P MordesElizabeth P Blankenhorn
Sep 28, 2002·Diabetes·Sheela RamanathanPhilippe Poussier
May 22, 2003·Toxicology and Applied Pharmacology·Ingrid KlötingJens van den Brandt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.